• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非人灵长类动物中疫苗引发罕见的 HIV 广谱中和抗体前体。

Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.

机构信息

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

IAVI Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Science. 2024 May 17;384(6697):eadj8321. doi: 10.1126/science.adj8321.

DOI:10.1126/science.adj8321
PMID:38753769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11309785/
Abstract

Germline-targeting immunogens hold promise for initiating the induction of broadly neutralizing antibodies (bnAbs) to HIV and other pathogens. However, antibody-antigen recognition is typically dominated by heavy chain complementarity determining region 3 (HCDR3) interactions, and vaccine priming of HCDR3-dominant bnAbs by germline-targeting immunogens has not been demonstrated in humans or outbred animals. In this work, immunization with N332-GT5, an HIV envelope trimer designed to target precursors of the HCDR3-dominant bnAb BG18, primed bnAb-precursor B cells in eight of eight rhesus macaques to substantial frequencies and with diverse lineages in germinal center and memory B cells. We confirmed bnAb-mimicking, HCDR3-dominant, trimer-binding interactions with cryo-electron microscopy. Our results demonstrate proof of principle for HCDR3-dominant bnAb-precursor priming in outbred animals and suggest that N332-GT5 holds promise for the induction of similar responses in humans.

摘要

种系靶向免疫原有望引发针对 HIV 和其他病原体的广泛中和抗体 (bnAb)。然而,抗体-抗原识别通常由重链互补决定区 3 (HCDR3)相互作用主导,种系靶向免疫原对 HCDR3 主导型 bnAb 的疫苗引发在人类或杂交动物中尚未得到证实。在这项工作中,用 N332-GT5 免疫接种,一种设计用于靶向 HCDR3 主导型 bnAb BG18 前体的 HIV 包膜三聚体,在 8 只恒河猴中的 8 只中引发了大量具有不同谱系的 bnAb 前体 B 细胞在生发中心和记忆 B 细胞中。我们通过冷冻电镜确认了 bnAb 模拟、HCDR3 主导、三聚体结合相互作用。我们的结果证明了在杂交动物中 HCDR3 主导型 bnAb 前体引发的原理,并表明 N332-GT5 有望在人类中诱导类似的反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b8/11309785/80a803c36338/nihms-2008143-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b8/11309785/ecf001a59f5b/nihms-2008143-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b8/11309785/eb69f66db31b/nihms-2008143-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b8/11309785/48a071f365e0/nihms-2008143-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b8/11309785/80a803c36338/nihms-2008143-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b8/11309785/ecf001a59f5b/nihms-2008143-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b8/11309785/eb69f66db31b/nihms-2008143-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b8/11309785/48a071f365e0/nihms-2008143-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59b8/11309785/80a803c36338/nihms-2008143-f0004.jpg

相似文献

1
Vaccine priming of rare HIV broadly neutralizing antibody precursors in nonhuman primates.在非人灵长类动物中疫苗引发罕见的 HIV 广谱中和抗体前体。
Science. 2024 May 17;384(6697):eadj8321. doi: 10.1126/science.adj8321.
2
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses.一种用于诱导广泛中和抗体反应的通用 HIV 疫苗设计策略。
Science. 2019 Dec 6;366(6470). doi: 10.1126/science.aax4380. Epub 2019 Oct 31.
3
Vaccination induces broadly neutralizing antibody precursors to HIV gp41.接种疫苗可诱导针对 HIV gp41 的广谱中和抗体前体。
Nat Immunol. 2024 Jun;25(6):1073-1082. doi: 10.1038/s41590-024-01833-w. Epub 2024 May 30.
4
mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies.mRNA-LNP HIV-1 三聚体增强剂引发广谱中和抗体前体。
Science. 2024 May 17;384(6697):eadk0582. doi: 10.1126/science.adk0582.
5
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors.人类免疫球蛋白库分析指导设计针对 HIV V2-顶点广谱中和抗体前体的疫苗起始免疫原。
Immunity. 2022 Nov 8;55(11):2149-2167.e9. doi: 10.1016/j.immuni.2022.09.001. Epub 2022 Sep 29.
6
HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.HIV-1疫苗。使用靶向种系的免疫原引发对HIV-1的广泛中和抗体反应。
Science. 2015 Jul 10;349(6244):156-61. doi: 10.1126/science.aac5894. Epub 2015 Jun 18.
7
Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction.基于突变的疫苗设计:一种开发 HIV 广谱中和抗体诱导增强免疫原的方法。
Cell Host Microbe. 2024 May 8;32(5):693-709.e7. doi: 10.1016/j.chom.2024.04.006. Epub 2024 Apr 25.
8
Strategies for induction of HIV-1 envelope-reactive broadly neutralizing antibodies.HIV-1 包膜反应性广谱中和抗体的诱导策略。
J Int AIDS Soc. 2021 Nov;24 Suppl 7(Suppl 7):e25831. doi: 10.1002/jia2.25831.
9
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies.种系靶向的黑猩猩 SIV 包膜糖蛋白激发新型 V2-顶点定向的交叉中和抗体。
mBio. 2023 Feb 28;14(1):e0337022. doi: 10.1128/mbio.03370-22. Epub 2023 Jan 11.
10
Diverse priming outcomes under conditions of very rare precursor B cells.在极罕见的前体B细胞条件下的多种启动结果。
Immunity. 2025 Apr 8;58(4):997-1014.e11. doi: 10.1016/j.immuni.2025.03.003. Epub 2025 Mar 31.

引用本文的文献

1
CryoEM Structures of Antibodies Elicited by Germline-Targeting HIV MPER Epitope-Scaffolds.靶向种系的HIV膜近端外部区域(MPER)表位支架引发的抗体的冷冻电镜结构
bioRxiv. 2025 Aug 19:2025.08.19.671101. doi: 10.1101/2025.08.19.671101.
2
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.在IAVI G001人体疫苗试验中引发的具有不同轻链的VRC01类广谱中和抗体前体的结构见解。
Proc Natl Acad Sci U S A. 2025 Aug 19;122(33):e2510163122. doi: 10.1073/pnas.2510163122. Epub 2025 Aug 11.
3
Structural basis of broad protection against influenza virus by human antibodies targeting the neuraminidase active site via a recurring motif in CDR H3.

本文引用的文献

1
mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies.mRNA-LNP HIV-1 三聚体增强剂引发广谱中和抗体前体。
Science. 2024 May 17;384(6697):eadk0582. doi: 10.1126/science.adk0582.
2
Characterization of the immunoglobulin lambda chain locus from diverse populations reveals extensive genetic variation.从不同人群中鉴定的免疫球蛋白 lambda 链基因座揭示了广泛的遗传变异。
Genes Immun. 2023 Feb;24(1):21-31. doi: 10.1038/s41435-022-00188-2. Epub 2022 Dec 21.
3
Vaccination induces HIV broadly neutralizing antibody precursors in humans.
通过互补决定区H3中反复出现的基序靶向神经氨酸酶活性位点的人类抗体对流感病毒广泛保护的结构基础
Nat Commun. 2025 Aug 1;16(1):7067. doi: 10.1038/s41467-025-62174-2.
4
Vaccination with an mRNA-encoded membrane-bound HIV envelope trimer induces neutralizing antibodies in animal models.用mRNA编码的膜结合HIV包膜三聚体进行疫苗接种可在动物模型中诱导中和抗体。
Sci Transl Med. 2025 Jul 30;17(809):eadw0721. doi: 10.1126/scitranslmed.adw0721.
5
The HIV-1 envelope glycoprotein: structure, function and interactions with neutralizing antibodies.人类免疫缺陷病毒1型包膜糖蛋白:结构、功能及与中和抗体的相互作用
Nat Rev Microbiol. 2025 Jul 23. doi: 10.1038/s41579-025-01206-6.
6
Scale-up and cGMP manufacturing of next-generation vaccine adjuvant saponin/MPLA nanoParticles (SMNP).下一代疫苗佐剂皂苷/MPLA纳米颗粒(SMNP)的扩大生产及cGMP生产
J Pharm Sci. 2025 Jul 19;114(9):103913. doi: 10.1016/j.xphs.2025.103913.
7
Virus glycoprotein nanodisc platform for vaccine design.用于疫苗设计的病毒糖蛋白纳米盘平台
bioRxiv. 2025 Jun 16:2025.05.02.651272. doi: 10.1101/2025.05.02.651272.
8
Functional, Immunogenetic, and Structural Convergence in Influenza Immunity between Humans and Macaques.人类与猕猴流感免疫中的功能、免疫遗传和结构趋同
bioRxiv. 2025 Feb 27:2025.02.21.639368. doi: 10.1101/2025.02.21.639368.
9
Transient glycan shield reduction induces CD4-binding site broadly neutralizing antibodies in SHIV-infected macaques.短暂的聚糖屏蔽减少在感染SHIV的猕猴中诱导出结合CD4位点的广谱中和抗体。
Cell Rep. 2025 Jun 24;44(6):115848. doi: 10.1016/j.celrep.2025.115848. Epub 2025 Jun 13.
10
Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial.在IAVI G001人体疫苗试验中引发的具有不同轻链的VRC01类广谱中和抗体前体的结构见解。
bioRxiv. 2025 May 27:2025.05.22.655646. doi: 10.1101/2025.05.22.655646.
接种疫苗可在人体内诱导产生 HIV 广谱中和抗体前体。
Science. 2022 Dec 2;378(6623):eadd6502. doi: 10.1126/science.add6502.
4
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors.人类免疫球蛋白库分析指导设计针对 HIV V2-顶点广谱中和抗体前体的疫苗起始免疫原。
Immunity. 2022 Nov 8;55(11):2149-2167.e9. doi: 10.1016/j.immuni.2022.09.001. Epub 2022 Sep 29.
5
Long-primed germinal centres with enduring affinity maturation and clonal migration.长潜伏期生发中心具有持久的亲和力成熟和克隆迁移。
Nature. 2022 Sep;609(7929):998-1004. doi: 10.1038/s41586-022-05216-9. Epub 2022 Sep 21.
6
Phylogenetic analysis of migration, differentiation, and class switching in B cells.B 细胞迁移、分化和类别转换的系统发生分析。
PLoS Comput Biol. 2022 Apr 25;18(4):e1009885. doi: 10.1371/journal.pcbi.1009885. eCollection 2022 Apr.
7
ABlooper: fast accurate antibody CDR loop structure prediction with accuracy estimation.ABlooper:快速准确的抗体 CDR 环结构预测及其准确性评估。
Bioinformatics. 2022 Mar 28;38(7):1877-1880. doi: 10.1093/bioinformatics/btac016.
8
A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity.一种颗粒状皂素/TLR 激动剂疫苗佐剂可改变淋巴液流动并调节适应性免疫。
Sci Immunol. 2021 Dec 3;6(66):eabf1152. doi: 10.1126/sciimmunol.abf1152.
9
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env.恒河猴的序贯免疫可诱导针对 HIV-1 Env 的 V3-聚糖补丁的异源中和抗体。
Sci Transl Med. 2021 Nov 24;13(621):eabk1533. doi: 10.1126/scitranslmed.abk1533.
10
DeGlyPHER: An Ultrasensitive Method for the Analysis of Viral Spike -Glycoforms.DeGlyPHER:一种分析病毒刺突糖型的超灵敏方法。
Anal Chem. 2021 Oct 12;93(40):13651-13657. doi: 10.1021/acs.analchem.1c03059. Epub 2021 Oct 1.